N-cyclic sulfonamido inhibitors of gamma secretase
申请人:Neitzel L. Martin
公开号:US20060035884A1
公开(公告)日:2006-02-16
The invention provides N-cyclic sulfonamido compounds for use in treating or preventing cognitive disorders, such as Alzheimer's Disease.
Compounds of particular interest are defined by Formula I, wherein R
4
, R
5
, R
6
, R
7
, and R
8
, are as described in the specification. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I as well as methods of treating cognitive disorders, including Alzheimer's disease using compounds of Formula I.
本发明提供了用于治疗或预防认知障碍(如阿尔茨海默病)的 N-环磺酰胺基化合物。
特别感兴趣的化合物由式 I 定义,其中 R
4
, R
5
, R
6
, R
7
和 R
8
如说明书所述。本发明还包括由式 I 化合物组成的药物组合物,以及使用式 I 化合物治疗认知障碍(包括阿尔茨海默病)的方法。
Burmistrov,S.I.; Karpishchenko,L.S., Journal of Organic Chemistry USSR (English Translation), 1975, vol. 11, p. 2264
作者:Burmistrov,S.I.、Karpishchenko,L.S.
DOI:——
日期:——
Mechanistic insight into thermal 1,3- and 1,5-sulfonyl migrations of N-arenesulfonylphenothiazines and N-arenesulfonylphenoxazines
作者:Jiandong Wang、Kwon-Il Son、Jiaxi Xu
DOI:10.1007/s00706-016-1661-6
日期:2016.9
AbstractThe substrate scope and mechanistic insight of the thermal-induced 1,3- and 1,5-sulfonyl migration reactions of various sulfonamides have been investigated. The results indicate that both N-arenesulfonylphenothiazines and N-arenesulfonylphenoxazines can undergo 1,3- and 1,5-sulfonyl migrations to afford the corresponding aryl sulfone derivatives in modest regioselectivities and yields under